Product screening
Antibodies
Proteins
Amyloid-β Polyclonal Antibody
Alias:Amyloid beta A4 protein;ABPP;APPI;APP;Alzheimer disease amyloid protein;Cerebral vascular amyloid peptide;CVAP;PreA4;Protease nexin-II;PN-II;[Cleaved into: N-APP;Soluble APP-alpha;S-APP-alpha;Soluble APP-beta;S-APP-beta;C99;Beta-amyloid protein 42;Beta-APP42;Beta-amyloid protein 40;Beta-APP40;C83;P3;42;P3;40;C80;Gamma-secretase C-terminal fragment 59;Amyloid intracellular domain 59;AICD-59;AID;59;Gamma-CTF;59;Gamma-secretase C-terminal fragment 57;Amyloid intracellular domain 57;AICD-57;AID;57;Gamma-CTF;57;Gamma-secretase C-terminal fragment 50;Amyloid intracellular domain 50;AICD-50;AID;50;Gamma-CTF;50;C31]
CatalogNo:HJRLT5773
Specifications
50μL;100μL
Delivery date
Spot
Target
Amyloid-β
Reactivity
Human,Rat,Mouse,
Application - After Update
WB,IF,ELISA
MW(Observed)
86kD,45kD
Host Species
Rabbit
Isotype
IgG
Modify
Unmodified
Recommended dilution ratio
WB 1:500-2000;IF/ICC1:100-500;ELISA 1:5000-20000
compose
Liquid in PBS containing 50％ glycerol, 0.5％ BSA and 0.02％ sodium azide.
Store
-15°C to -25°C/1 year（Do not lower than -25°C）
Soncentration
1 mg/ml
Clonality
Polyclonal
Immunogen
Synthesized peptide derived from Amyloid-β at AA range: 631-680
Specificity
Amyloid-β Polyclonal Antibody detects endogenous levels of Amyloid-β
Gene name
APP
Protein name
Amyloid beta A4 protein, Amyloid-β, Aβ
Organism-1
Human